Julian Esteve-Rudd

Julian Esteve-Rudd has extensive work experience in the field of ophthalmology. Julian is currently the Head of Ophthalmology at SpliceBio since November 2022. Prior to that, they worked at Gyroscope Therapeutics from 2019 to 2022, holding the positions of Associate Director of Preclinical Ophthalmology, Group Lead of Preclinical Ophthalmology, and Principal Scientist. In these roles, they played a key role in the advancement of preclinical ophthalmology projects.

Julian also worked at Bayer from 2015 to 2019, where they held the position of Research Scientist and Laboratory Head of Ophthalmology. Julian led preclinical development activities, managed cross-functional teams, and collaborated with academic partners. Their responsibilities included target identification, establishing cell-based assays, and managing laboratory staff.

Before joining the industry, Julian worked as a Postdoctoral Research Fellow at UCLA Health from 2010 to 2015. Their research focused on retinal dystrophies and ciliopathies associated with age-related macular degeneration and other diseases. Julian also holds a Ph.D. in Neurobiology from Universidad de Alicante, where they conducted research as a Ph.D. Researcher. Additionally, they spent time as a Visiting Graduate Student at the University of Wisconsin-Madison in 2006.

Overall, Julian Esteve-Rudd has made significant contributions to the field of ophthalmology through their extensive research and leadership roles in both academic and industry settings.

Julian Esteve-Rudd's education history begins with their Bachelor of Science degree in Biology from Universitat d'Alacant, which they obtained from 2000 to 2004. Julian then pursued their PhD in the field of Neurobiology of the Retina at Universidad de Alicante from 2005 to 2010. Following their PhD, Julian Esteve-Rudd furthered their academic journey by becoming a postdoctoral scholar at the David Geffen School of Medicine at UCLA, specializing in Cellular and Molecular Biology of the retina from 2010 to 2015.